Automation from GNF Systems Opens New Therapeutic Opportunities

GNF scientists introduce a new high throughput screening system that enables fully automated, high throughput flow cytometry. This new system will enable screening of more complex, disease relevant assays while decreasing the time from screen to lead identification. This effort has facilitated our ability to run phenotypic screens across multiple disease areas, enabling discovery of novel drugs.